Marc van der Kamp
Overview
Explore the profile of Marc van der Kamp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jackering A, van der Kamp M, Strodel B, Zinovjev K
J Chem Inf Model
. 2024 Sep;
64(19):7544-7554.
PMID: 39344272
Plastic-degrading enzymes, particularly poly(ethylene terephthalate) (PET) hydrolases, have garnered significant attention in recent years as potential eco-friendly solutions for recycling plastic waste. However, understanding of their PET-degrading activity and influencing...
2.
Alogaidi A, Armstrong F, Bakshi A, Bornscheuer U, Brown G, Bruton I, et al.
Faraday Discuss
. 2024 Aug;
252(0):480-506.
PMID: 39189046
No abstract available.
3.
Acevedo-Rocha C, Berlicki L, Bornscheuer U, Campopiano D, Chaiyen P, civic J, et al.
Faraday Discuss
. 2024 Aug;
252(0):127-156.
PMID: 39177511
No abstract available.
4.
Acevedo-Rocha C, Bakshi A, Bornscheuer U, Campopiano D, civic J, Drienovska I, et al.
Faraday Discuss
. 2024 Aug;
252(0):354-386.
PMID: 39175251
No abstract available.
5.
O Loughlin J, Zinovjev K, Napolitano S, van der Kamp M, Rubini M
Protein Sci
. 2023 Dec;
33(2):e4877.
PMID: 38115231
The cis/trans isomerization of peptidyl-prolyl peptide bonds is often the bottleneck of the refolding reaction for proteins containing cis proline residues in the native state. Proline (Pro) analogues, especially C4-substituted...
6.
Hassan N, Gregson C, Tang H, van der Kamp M, Leo P, McInerney-Leo A, et al.
J Bone Miner Res
. 2023 Feb;
38(5):678-691.
PMID: 36824040
Anabolic treatment options for osteoporosis remain limited. One approach to discovering novel anabolic drug targets is to identify genetic causes of extreme high bone mass (HBM). We investigated a pedigree...
7.
Poole A, Karuppiah V, Hartt A, Haidar J, Moureau S, Dobrzycki T, et al.
Nat Commun
. 2022 Sep;
13(1):5333.
PMID: 36088370
Neoantigens derived from somatic mutations are specific to cancer cells and are ideal targets for cancer immunotherapy. KRAS is the most frequently mutated oncogene and drives the pathogenesis of several...
8.
Suardiaz R, Lythell E, Hinchliffe P, van der Kamp M, Spencer J, Fey N, et al.
Org Biomol Chem
. 2021 Feb;
19(17):3813-3819.
PMID: 33606866
The mcr-1 gene encodes a membrane-bound Zn2+-metalloenzyme, MCR-1, which catalyses phosphoethanolamine transfer onto bacterial lipid A, making bacteria resistant to colistin, a last-resort antibiotic. Mechanistic understanding of this process remains...
9.
Ge Y, van der Kamp M, Malaisree M, Liu D, Liu Y, Mulholland A
J Comput Aided Mol Des
. 2017 Oct;
31(11):995-1007.
PMID: 28994029
Cdc25 phosphatase B, a potential target for cancer therapy, is inhibited by a series of quinones. The binding site and mode of quinone inhibitors to Cdc25B remains unclear, whereas this...
10.
Rodriguez A, Oliva C, Gonzalez M, van der Kamp M, Mulholland A
J Phys Chem B
. 2007 Oct;
111(44):12909-15.
PMID: 17935316
The link atom (LA) and the generalized hybrid orbital (GHO) quantum mechanical/molecular mechanics (QM/MM) boundary treatment methods are compared, in the context of the acylation process (the rate-limiting step) involving...